Patients frequently present ophthalmologists with complaints regarding eyelid lesions. The comprehensive practitioner will detect abnormal lesions of the eyelids, as well as detect issues which may not be the presenting question or creating symptoms, but still warrant treatment. This module reviews malignant eyelid and periocular lesions helping in their detection and management.
This issue covers nonmelanoma skin cancers such as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), as well as superficial and malignant melanomas, sebaceous and Merkel cell carcinoma and other malignancies.
Upon completion of this module, the reader should be able to:
- Summarize the key features and primary management of BCC and SCC;
- Describe adjunctive treatment options for challenging cases of BCC and SCC;
- Recognize the unique nature of cutaneous melanoma in terms of clinical appearance, tumor biology, systemic dissemination and management strategies;
- List other rare eyelid malignancies that have metastatic potential;
- Describe a systematic approach for reconstruction of soft-tissue defects of a full-thickness eyelid, of eyelid skin and of the periocular region.
Authors: Richard A. Burgett, MD, FACS and Jeremy D. Clark, MD
Consultants: Alison B. Huggins, MD, Mark J. Lucarelli, MD, FACS, and John W. Shore, MD
Focal Points issues are practical, hands-on discussions of the clinical issues you face daily. Each issue delivers high-quality, trusted ophthalmic information written and reviewed by leading experts.
Subscribers receive 12 issues a year, plus access to the Focal Points digital archive.
To access this issue from your laptop or desktop computer, log in to www.aao.org/myonlineproducts with your Academy username and password.
To access this issue from your smartphone or tablet, use the free AAO eBooks app.
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.